Evodiamine |
Influence on cell cycle |
Western Blot |
50.00 µM |
Bcl-7402 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
5.00 µM |
Bcl-7402 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
25.00 µM |
Bcl-7402 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
50.00 µM |
Bcl-7402 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
5.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
25.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
50.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
5.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
25.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
50.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
5.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
25.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell cycle |
Western Blot |
50.00 µM |
QGY-7701 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
12.50 µM |
Hep2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
25.00 µM |
Hep2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
50.00 µM |
Hep2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
100.00 µM |
Hep2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
12.50 µM |
LO-2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
25.00 µM |
LO-2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
50.00 µM |
LO-2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on cell viability |
MTT |
100.00 µM |
LO-2 |
Homo sapiens |
|
|
|
Evodiamine |
Influence on tumor growth |
Tumor volume |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
Tumor volume |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
Tumor weight |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
Tumor weight |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
Immunohistochemistry |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
p-STAT3 (Tyr705) |
|
Evodiamine |
Influence on tumor growth |
Immunohistochemistry |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
p-STAT3 (Tyr705) |
|
Evodiamine |
Influence on tumor growth |
Immunohistochemistry |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
STAT3 |
|
Evodiamine |
Influence on tumor growth |
Immunohistochemistry |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
STAT3 |
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
10.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|
Evodiamine |
Influence on tumor growth |
RT-qPCR |
20.00 mg/kg |
Hep2 (xenograft) |
Mus musculus |
|
|
|